Exchange Auditorium: Metastatic Disease

Back

Exchange Auditorium: Metastatic Disease

11.30
Managing ER+ disease:                 
Professor Stephen Johnston

11.50
Predicting outcome in metastatic breast cancer: 
Dr Aleix Prat

12.10
Evolution of resistance:
Professor Adrian Harris

12.30
Selected Free Communication:
RADICL phase lb/lla study of AZD4547 combined with anastrozole or letrozole in AI resistant ER+ breast cancer patients
Professor Michael Seckl, Imperial College London

Chairs: Professor Andrew Tutt & Dr Catherine Harper-Wynne